Cost-effectiveness of childhood pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation

BACKGROUND: Ethiopia was among the 15 countries that, together accounted for 64% of the world’s severe episodes of pneumonia among children below the age of 5 in 2011. To reduce this burden, the 10-valent pneumococcal conjugate vaccine (PCV 10) was introduced into the general childhood national immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kebede, Tayue Tateke, Svensson, Mikael, Addissie, Adamu, Trollfors, Birger, Andersson, Rune
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688319/
https://www.ncbi.nlm.nih.gov/pubmed/31399030
http://dx.doi.org/10.1186/s12889-019-7423-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688319/
https://www.ncbi.nlm.nih.gov/pubmed/31399030
http://dx.doi.org/10.1186/s12889-019-7423-8

Ejemplares similares